Latest news and articles about new treatments from NEX English
A team of international researchers led by scientists from the University of Manchester has discovered the most detailed image yet of the relationship between genes and eye function, paving the way for a better understanding of the causes of vision loss.
Researchers at Weill Cornell Medicine have uncovered an unexpected immune mechanism that could reshape our understanding of immune regulation in the intestines. This discovery may have significant implications for treating inflammatory diseases.
In Singapore, Chloe Ng struggled with severe eczema, leading to open wounds on her fingers. After years of trying various treatments, she found relief through new therapies at the National Skin Centre in 2021.
Recent studies have revealed promising signals that could help in the fight against the novel coronavirus. These discoveries open new avenues in medical research at a critical time as the world continues to grapple with the pandemic's effects.
Reports indicate that the U.S. Food and Drug Administration (FDA) intends to permit the production of 14 peptides that were previously banned due to safety concerns. This decision comes amid increasing calls for the use of these substances in medical treatments.
Biogen, a company specializing in drug development, has announced its acquisition of Apellis Pharmaceuticals for <strong>$5.6 billion</strong>. This move aims to expand Biogen's capabilities in treating kidney diseases, addressing the growing need for effective therapies.
Merck & Co. is in advanced talks to acquire Turners Pharmaceuticals, a move aimed at strengthening its portfolio of drugs and treatments. This acquisition reflects Merck's strategy to expand its presence in the global pharmaceutical market.